Is a serum creatinine of 1.14 mg/dL with an estimated glomerular filtration rate of 45 mL/min/1.73 m² normal for a patient in their late 80s?

Is a Serum Creatinine of 1.14 mg/dL with eGFR of 45 mL/min/1.73 m² Normal for a Patient in Their Late 80s?

No, this is not normal—even for a patient in their late 80s, an eGFR of 45 mL/min/1.73 m² represents Stage 3 chronic kidney disease (CKD) with moderate renal impairment that carries significant clinical implications for mortality, cardiovascular disease risk, and medication dosing. 1

Understanding the Clinical Context

While GFR naturally declines with aging (approximately 8 mL/min per decade after age 40), the National Kidney Foundation guidelines explicitly state that decreased GFR in the elderly is an independent predictor of adverse outcomes including death and cardiovascular disease, and therefore the definition of CKD remains the same regardless of age. 1

CKD Staging Classification

According to internationally recommended National Kidney Foundation criteria, this patient falls into Stage 3 CKD (GFR 30-59 mL/min/1.73 m²), defined as moderate decrease in GFR. 1

• Stage 1: GFR ≥90 mL/min/1.73 m² (normal or increased)
• Stage 2: GFR 60-89 mL/min/1.73 m² (mild decrease)
• Stage 3: GFR 30-59 mL/min/1.73 m² (moderate decrease) ← This patient
• Stage 4: GFR 15-29 mL/min/1.73 m² (severe decrease)
• Stage 5: GFR <15 mL/min/1.73 m² (kidney failure)

Critical Pitfall: Serum Creatinine Misleads in the Elderly

The serum creatinine of 1.14 mg/dL appears deceptively "normal" but masks significant renal impairment in elderly patients. 1 This is a common and dangerous clinical trap.

Why Creatinine Alone is Unreliable

• Serum creatinine ranges of 0.8-1.3 mg/dL in men and 0.6-1.0 mg/dL in women represent "normal" values only in patients with normal renal function. 1
• As muscle mass decreases with age, serum creatinine levels decrease but this is not matched by preserved renal function. 1
• A creatinine of 1.2 mg/dL may correspond to a creatinine clearance of 110 mL/min in a 30-year-old 90 kg male athlete but only 40 mL/min in a 75-year-old woman weighing 65 kg. 1
• Among cancer patients with "normal" serum creatinine measurements, one in five had asymptomatic renal insufficiency. 1
• The K/DOQI guidelines explicitly state that serum creatinine alone should not be used to assess kidney function. 1

Clinical Implications of Stage 3 CKD

Mortality and Cardiovascular Risk

Approximately 17% of persons older than 60 years have an eGFR <60 mL/min/1.73 m², and this decreased GFR is an independent predictor of death and cardiovascular disease. 1 The prevalence of complications increases significantly below this threshold. 1

Medication Dosing Requirements

This level of renal function mandates dose adjustments for renally cleared medications to prevent toxicity. 1

• Before initiating potentially toxic drug therapy in the elderly, hydration status should be assessed and optimized, and renal function must be evaluated. 1
• For drugs with narrow therapeutic index cleared by the kidney, standard doses will clear more slowly and result in significantly increased drug exposure, potentially leading to major organ toxicity. 1
• Consensus guidelines recommend avoiding certain medications entirely below specific GFR thresholds (e.g., chlorpropamide, glyburide, nitrofurantoin, spironolactone at creatinine clearance <30 mL/min). 1

Accuracy Concerns with eGFR Equations in the Elderly

Multiple studies demonstrate that commonly used eGFR equations (CKD-EPI, MDRD) significantly overestimate actual renal function in elderly patients, particularly those over 80 years old. 2, 3, 4, 5

• In octogenarian inpatients, only 9-17% of patients fell within acceptable limits of agreement between predicted and measured creatinine clearance. 2
• The MDRD and CKD-EPI equations overestimated creatinine clearance by 29% and 18% respectively in patients with mean age 81 years, leading to dose calculation errors for many drugs. 3
• The BIS1 (Berlin Initiative Study) equation, specifically validated for patients over 70 years, may provide more accurate estimates in this age group. 5

Recommended Clinical Actions

Given the Stage 3 CKD classification, this patient requires:

1. Comprehensive medication review with dose adjustments for all renally cleared drugs 1
2. Evaluation for proteinuria/albuminuria to further risk-stratify (albumin-creatinine ratio >30 mg/g indicates kidney damage) 1
3. Assessment for CKD complications including anemia, bone mineral disorders, and cardiovascular disease 1
4. Avoidance of nephrotoxic agents and drugs primarily excreted by the kidneys when safer alternatives exist 1, 2
5. Consider measured creatinine clearance (24-hour urine collection) if precise dosing is needed for narrow therapeutic index drugs, as eGFR equations may overestimate true renal function 2, 3, 4

The common clinical error is dismissing mildly elevated creatinine as "normal for age"—this patient has clinically significant renal impairment requiring active management to prevent adverse outcomes.